Please Wait.....
Report
Global In Silico Clinical Trials Market Report and Forecast 2023-2031
Market Report I 2023-07-07 I 140 Pages I EMR Inc.
Global In Silico Clinical Trials Market Report and Forecast 2023-2031
Global In Silico Clinical Trials Market Outlook:
The global in silico clinical trials market size was valued at USD 3.1 billion in 2022, driven by the rise in demand of personalized medicine across the globe. The market size is anticipated to grow at a CAGR of 7.42% during the forecast period of 2023-2031 to achieve a value of USD 6 billion by 2031.
In Silico Clinical Trials: Introduction
In Silico Clinical Trials (ISCT) is an emerging field that utilizes computer modeling and simulation techniques to conduct virtual clinical trials. Unlike traditional clinical trials, which involve testing new drugs or medical interventions on human subjects, ISCT leverages computational models to simulate the behavior of drugs, medical devices, or treatment strategies in virtual patient populations.
ISCT offers several advantages over conventional clinical trials. It allows researchers to explore a wide range of scenarios, predict the outcomes of different treatment strategies, and optimize clinical trial designs before conducting costly and time-consuming human trials. It also enables the assessment of the safety and efficacy of interventions in diverse patient populations, including those with rare diseases or specific genetic profiles.
Key Trends in the Global in Silico Clinical Trials Market
There are several key trends in the market and some of them are:
- Increasing Adoption of Artificial Intelligence and Machine Learning: Artificial intelligence (AI) and machine learning (ML) technologies are being integrated into ISCT to enhance the accuracy and predictive capabilities of the models. These advanced algorithms can analyze large datasets, identify patterns, and make predictions about treatment outcomes, helping to optimize clinical trial designs and personalize treatment approaches.
- Integration of Real-World Data: Real-world data, including electronic health records, wearable device data, and genomic information, are being incorporated into ISCT models. By leveraging this real-world data, researchers can enhance the realism and validity of the virtual patient populations, enabling more accurate predictions of treatment responses and outcomes.
- Regulatory Framework Development: Regulatory bodies are recognizing the potential of ISCT and working towards developing guidelines and frameworks to ensure the reliability, validity, and regulatory acceptance of in silico trial results. These efforts aim to establish standards and protocols for model validation, data quality, and transparency in ISCT, enabling their use in regulatory decision-making processes.
- Collaboration and Partnerships: Collaboration among academia, industry, and regulatory bodies is becoming more prevalent in the field of ISCT. These collaborations facilitate the sharing of knowledge, expertise, and resources, leading to the development of more robust and reliable in silico trial platforms. It also helps to address the challenges associated with data availability, model validation, and regulatory acceptance.
- Ethical Considerations and Patient Engagement: As ISCT progresses, ethical considerations related to data privacy, informed consent, and patient rights are gaining attention. Patient engagement in the development and implementation of ISCT models and their participation in decision-making processes are key trends to ensure that the technology aligns with patient values and preferences.
Global In Silico Clinical Trials Market Segmentations
Market Breakup by Industry Type
- Medical Devices
- Pharmaceuticals
Market Breakup by Therapeutic Area
- Oncology
- Infectious Disease
- Hematology
- Cardiology
- Dermatology
- Neurology
- Diabetes
- Others
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global In Silico Clinical Trials Market Scenario
The market for in silico clinical trials (ISCT) is experiencing significant growth and is poised for further expansion in the coming years. ISCT offers a paradigm shift in the way clinical trials are conducted, bringing numerous benefits to the healthcare and pharmaceutical industries. The market is driven by the increasing need for more efficient, cost-effective, and personalized drug development processes.
ISCT eliminates many of the challenges associated with traditional clinical trials, such as the high cost, lengthy timelines, and ethical concerns related to human subjects. By conducting virtual trials using computational models, ISCT enables researchers to explore a wide range of scenarios, optimize trial designs, and make more informed decisions before moving to human trials. This approach leads to faster drug development, reduced costs, and improved patient safety.
One of the key factors driving the market growth is the rapid advancements in technology, particularly in artificial intelligence, machine learning, and big data analytics. These technologies enhance the accuracy and predictive capabilities of ISCT models, enabling researchers to analyze vast amounts of data, identify patterns, and generate insights for drug discovery and development. The integration of real-world data further enhances the realism and applicability of ISCT models, allowing for more personalized treatment strategies.
In conclusion, the market for In Silico Clinical Trials is rapidly growing, driven by technological advancements, regulatory support, and collaborations among stakeholders. The adoption of ISCT promises to revolutionize the drug development process, enabling faster and more cost-effective trials while prioritizing patient safety and personalized treatment approaches. As the market continues to evolve, further advancements in technology, regulatory frameworks, and collaborative efforts will shape its trajectory and unlock its full potential.
Global In Silico Clinical Trials Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Dassault Systemes SE
- Certara Inc.
- Insilico Medicine
- GNS Healthcare Inc.
- The AnyLogic Company
- Novadiscovery SAS
- InSilicoTrials Technologies SpA
- Immunetrics Inc.
- CATO SMS
- Evotec SE
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global In Silico Clinical Trials Market Overview
3.1 Global In Silico Clinical Trials Market Historical Value (2016-2022)
3.2 Global In Silico Clinical Trials Market Forecast Value (2023-2031)
4 Global In Silico Clinical Trials Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter's Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global In Silico Clinical Trials Market Segmentation
5.1 Global In Silico Clinical Trials Market by Industry Type
5.1.1 Market Overview
5.1.2 Medical Devices
5.1.3 Pharmaceuticals
5.2 Global In Silico Clinical Trials Market by Therapeutic Area
5.2.1 Market Overview
5.2.2 Oncology
5.2.3 Infectious Disease
5.2.4 Hematology
5.2.5 Cardiology
5.2.6 Dermatology
5.2.7 Neurology
5.2.8 Diabetes
5.2.9 Others
5.3 Global In Silico Clinical Trials Market by Phase
5.3.1 Market Overview
5.3.2 Phase I
5.3.3 Phase II
5.3.4 Phase III
5.3.5 Phase IV
5.4 Global In Silico Clinical Trials Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America In Silico Clinical Trials Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe In Silico Clinical Trials Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific In Silico Clinical Trials Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America In Silico Clinical Trials Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa In Silico Clinical Trials Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Dassault Systemes SE
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Certara Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Insilico Medicine
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 GNS Healthcare Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 The AnyLogic Company
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Novadiscovery SAS
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 InSilicoTrials Technologies SpA
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Immunetrics Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 CATO SMS
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Evotec SE
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certificationsa
17 Global In Silico Clinical Trials Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security